The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)
NCT: NCT06315023 · ENROLLING_BY_INVITATION
Brief Summary
The purpose of this post-market surveillance study will be to evaluate the real-world use of the DETOUR System in treated patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis \> 70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments.
Frequently Asked Questions
What is The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)?
The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry) is a clinical trial registered under NCT06315023. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT06315023?
The current status of NCT06315023 (The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)) is: ENROLLING_BY_INVITATION.
When did The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry) start?
The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry) started on 2023-10-06.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.